Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Bone Marrow Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bone Marrow Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Bone Marrow Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
797 pages
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020
US$ 2,500.00
... The Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Immunodeficiency Virus (HIV) Infections (AIDS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
1285 pages
Pressure Ulcers - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pressure Ulcers (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
32 pages
Complex Regional Pain Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... news and press releases. The Complex Regional Pain Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic ...
August 2020
65 pages
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sandhoff Disease (Jatzkewitz-Pilz Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
45 pages
Osteogenesis Imperfecta - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteogenesis Imperfecta (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteogenesis Imperfecta and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
68 pages
Familial Adenomatous Polyposis - Pipeline Review, H2 2020
US$ 2,000.00
... . The Familial Adenomatous Polyposis (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Familial Adenomatous Polyposis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
71 pages
Crigler-Najjar Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Crigler-Najjar Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Crigler-Najjar Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
39 pages
Contrast Induced Nephropathy - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Contrast Induced Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
46 pages
Ragweed Pollen Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ragweed Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Ragweed Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
35 pages
Osteomyelitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteomyelitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Osteomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
55 pages
Coccidioidomycosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Coccidioidomycosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Coccidioidomycosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
81 pages
Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H3N2 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
163 pages
Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Granulomatosis with Polyangiitis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Granulomatosis with Polyangiitis (Wegener's Granulomatosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
119 pages
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020
US$ 2,000.00
... Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasal Polyps (Nasal Polyposis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
90 pages
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis (Atopic Eczema) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
684 pages
Alpha L-Iduronidase - Pipeline Review, H2 2020
US$ 3,500.00
Alpha L-Iduronidase - Pipeline Review, H2 2020 Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid res...
August 2020
66 pages
Apoptosis Regulator BAX - Pipeline Review, H2 2020
US$ 3,500.00
Apoptosis Regulator BAX - Pipeline Review, H2 2020 Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded by the BA...
August 2020
45 pages
Bromodomain Containing Protein 2 - Pipeline Review, H2 2020
US$ 3,500.00
Bromodomain Containing Protein 2 - Pipeline Review, H2 2020 According to the recently published report 'Bromodomain Containing Protein 2 - Pipeline Review, H2 2020'; Bromodomain Containing Protein 2...
August 2020
76 pages
Bromodomain Containing Protein 3 - Pipeline Review, H2 2020
US$ 3,500.00
Bromodomain Containing Protein 3 - Pipeline Review, H2 2020 Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) pipeline Target constitutes close to 11 molecules. Out of which approximatel...
August 2020
74 pages
Exportin 1 - Pipeline Review, H2 2020
US$ 3,500.00
Exportin 1 - Pipeline Review, H2 2020 Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 8 molecules. The latest report Exportin 1 - Pipeline R...
August 2020
121 pages
Frataxin Mitochondrial - Pipeline Review, H2 2020
US$ 3,500.00
Frataxin Mitochondrial - Pipeline Review, H2 2020 According to the recently published report 'Frataxin Mitochondrial - Pipeline Review, H2 2020'; Frataxin Mitochondrial (Friedreich Ataxia Protein or...
August 2020
66 pages
Iduronate 2 Sulfatase - Pipeline Review, H2 2020
US$ 3,500.00
Iduronate 2 Sulfatase - Pipeline Review, H2 2020 Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 9 molecules. Ou...
August 2020
65 pages
Leukotriene A 4 Hydrolase - Pipeline Review, H2 2020
US$ 3,500.00
Leukotriene A 4 Hydrolase - Pipeline Review, H2 2020 Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Leukotriene A4 hydrolase (LTA4H) is an enzyme wh...
August 2020
50 pages
Prostate Specific Antigen - Pipeline Review, H2 2020
US$ 3,500.00
Prostate Specific Antigen - Pipeline Review, H2 2020 According to the recently published report 'Prostate Specific Antigen - Pipeline Review, H2 2020'; Prostate Specific Antigen (Gamma Seminoprotein...
August 2020
82 pages
Tyrosine Protein Kinase Mer - Pipeline Review, H2 2020
US$ 3,500.00
Tyrosine Protein Kinase Mer - Pipeline Review, H2 2020 Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) pipeline Target constitutes close...
August 2020
74 pages
Bromodomain Containing Protein 4 - Pipeline Review, H2 2020
US$ 3,500.00
Bromodomain Containing Protein 4 - Pipeline Review, H2 2020 Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Bromodomain-containing protein 4 is a protein encoded by the BRD4 gene. It play...
August 2020
160 pages
Cell Division Protein FtsZ - Pipeline Review, H2 2020
US$ 3,500.00
Cell Division Protein FtsZ - Pipeline Review, H2 2020 Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms a contractile r...
August 2020
36 pages
Dystrophin - Pipeline Review, H2 2020
US$ 3,500.00
Dystrophin - Pipeline Review, H2 2020 According to the recently published report 'Dystrophin - Pipeline Review, H2 2020'; Dystrophin (DMD) pipeline Target constitutes close to 50 molecules. Out of w...
August 2020
128 pages
Gorlin Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
Gorlin Syndrome - Pipeline Review, H2 2020 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome - Pipeline Review, H2 2020, provides an overview of the...
August 2020
166 pages
Protein Phosphatase 2A - Pipeline Review, H2 2020
US$ 3,500.00
Protein Phosphatase 2A - Pipeline Review, H2 2020 According to the recently published report 'Protein Phosphatase 2A - Pipeline Review, H2 2020'; Protein Phosphatase 2A (PP2A or EC 3.1.3.16) pipelin...
August 2020
50 pages
Rheumatoid Arthritis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
1191 pages
Urinary Incontinence - Pipeline Review, H2 2020
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
80 pages
Autism - Pipeline Review, H2 2020
US$ 2,000.00
... . The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
173 pages
Erectile Dysfunction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
156 pages
Male Hypogonadism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
108 pages
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
1101 pages
Otitis Media - Pipeline Review, H2 2020
US$ 2,000.00
... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
86 pages
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
419 pages
Iron Deficiency Anemia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Iron Deficiency Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Iron Deficiency Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
96 pages
